drugs for overactive bladder (OAB)

Innovus Pharma Launches its Clinically Proven UriVarx™ Product for Bladder Health in the United States

Innovus Pharmaceuticals, Inc. (“Innovus Pharma”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced the launch of UriVarx™ in the U.S. UriVarx™ is clinically proven to reduce urinary urgency, accidents and both day and night frequency in Overactive Bladder (“OAB”) and Urinary Incontinence (“UI”) patients.  Read more.

Source: BusinessWire, December 1, 2016

Posted in News and tagged , , , , .